Lombard Medical (EVAR) Earning Somewhat Positive News Coverage, Analysis Shows

News headlines about Lombard Medical (NASDAQ:EVAR) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Lombard Medical earned a media sentiment score of 0.03 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 45.5011678433839 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Shares of Lombard Medical (NASDAQ EVAR) remained flat at $0.45 during midday trading on Friday. 14,899 shares of the company’s stock were exchanged. The company’s market capitalization is $12.58 million. The stock’s 50 day moving average is $0.51 and its 200 day moving average is $0.56. Lombard Medical has a 1-year low of $0.40 and a 1-year high of $1.15.

COPYRIGHT VIOLATION WARNING: “[[title]]” was first reported by [[site]] and is owned by of [[site]]. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at [[permalink]].

Lombard Medical Company Profile

Lombard Medical, Inc is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company’s Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees.